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Abstract: Gene therapy is a technique that is currently under expansion and development. Recent
advances in genetic medicine have paved the way for a broader range of therapies and laid the
groundwork for next-generation technologies. A terminally substituted difluorene-diester Schiff
Base calix[4]arene has been studied in this work as possible nanovector to be used in gene therapy.
Changes to luminescent behavior of the calixarene macrocycle are reported in the presence of ct-DNA.
The calixarene macrocycle interacts with calf thymus DNA (ct-DNA), generating changes in its
conformation. Partial double-strand denaturation is induced at low concentrations of the calixarene,
resulting in compaction of the ct-DNA. However, interaction between calixarene molecules themselves takes place at high calixarene concentrations, favoring the decompaction of the polynucleotide.
Based on cytotoxicity studies, the calixarene macrocycle investigated has the potential to be used as a
nanovehicle and improve the therapeutic efficacy of pharmacological agents against tumors.
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1. Introduction
Between the late 20th and early 21st centuries, 2335 gene therapy clinical trials were
either completed ongoing, or approved worldwide. The number of clinical trials peaked in
2015, with a total of 163 trials. Most clinical trials of gene therapies have been conducted to
treat specific cancerous diseases [1].
Gene therapy was designed to replace faulty genes or interrupt their expression.
Following its successes and rapid development, there is a greater need for preparing
highly efficient vectors, with low cytotoxicity, which can cross the cell membrane and
the cytoplasm and release the genetic material into the cell nucleus. There are viral and
non-viral vectors. Viral vectors often elicit an immune response in vivo, so researchers
in recent years have focused more attention on non-viral vectors. These vectors bind to
the polynucleotide, inducing a conformational change toward a more compact state. This
phenomenon is called compaction or condensation. There is considerable documentation
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in the bibliography on the use of cationic molecules to condense DNA and form complexes
to facilitate gene transfer both in vitro and in vivo [2,3].
In recent years, many reviews have discussed the use of different macrocycles as
non-viral vectors for gene transfection. Jiménez Blanco et al. [4] summarized the properties
of preorganized macromolecular systems such as cyclodextrins, calixarenes, pillarenes,
fullerenes, cyclopeptides, and cyclotrehalans, which are capable of self-assembling into
nano-sized particles to allow a safe release of nucleic acids. Zhou et al. [5] reviewed
the progress made in the condensation of ct-DNA molecules using nanostructure-based
vectors and highlighted the elucidation of the complex structure formed with ct-DNA using
different microscopic techniques. Rodik et al. [6] provided an overview of calixarenes, and
related macrocycles, as vehicles in gene delivery, emphasizing the importance of having
a preorganized scaffold incorporating alkyl chains in the structure. In that review, the
authors pointed researchers to performing in vivo tests as a definitive step for evaluating
the potential of these new materials in gene therapy products.
In relation to calixarenes, they can be functionalized with cationic groups on their
upper rim and alkyl chains on their lower rim (or vice versa), thus making them promising vectors for the delivery of new genetic material. Multivalent platforms with guanidinium groups based on calixarenes have been used with great success in gene transfer.
Sansone et al. [7] studied the capacity of these macrocycles in the binding, condensation,
and transport of calf thymus DNA through cell membranes. In a systematic study, it was
determined that the calix[4]arenes in the cone conformation lead to a more compact state
of ct-DNA, due to the arrangement of their lipophilic chains. Additionally, an increase in
the number of phenolic units in these receptors causes a partial compaction of the polynucleotide, as shown by AFM measurements. Calix[4]arenes in cone conformation only have
been found to facilitate cell transfection effectively, which is indicative of a balance between
hydrophobic and electrostatic interactions.
Rodik et al. [8] designed a protocol that optimized the ct-DNA compaction process
in the presence of cationic amphiphilic calixarenes micelles, which were calix[4]arenes
with choline groups and long hydrocarbon chains on their polar head. They generated
aggregates of about 50 nm with suitable properties for transfection. In fact, efficient uptake
of these vectors by adenocarcinoma cells from cervix/uterus (HeLa) was demonstrated by
fluorescence microscopy [8]. In a later study, they further improved the polynucleotide
condensation process by lengthening the alkyl chains, which led to smaller aggregates with
low polydispersity index, thus promoting more efficiently gene transfection and decreasing
cytotoxicity. On the other hand, it was observed that changes in the nature of the groups at
the polar head do not play a fundamental role in this process.
With the aim of increasing the cooperativity phenomenon, Lalor et al. [9] prepared
functionalized cationic multi-calixarenes, where one calix[4]arene acted as the central unit
of the superstructure, which also contained four other calix[4]arene molecules, linked by
short polar spacers groups. Each terminal macrocycle has a glycine residue with a free
aliphatic amine at its upper terminus. Binding between multimeric calixarenes and ct-DNA
was observed at lower macrocycle concentrations than when binding to a single calixarene
structure, pointing to a cooperative effect. Furthermore, cytotoxicity for different cell lines
was negligible and gene transfection was confirmed in Chinese hamster ovary (CHO) cells.
Rallaud et al. [10] demonstrated that not only electrostatic-type interactions take place
between cationic calixarenes and ct-DNA, but there may also be interactions with the
major or minor groove of the polynucleotide. For this purpose, they used amphiphilic
calix[4]arenes functionalized with guanidinium groups. It was observed that dimers
of these calixarenes interact with the polynucleotide, inducing conformational changes
through interactions with the major groove of ct-DNA. These changes depended on the
structure of the macrocycle [11,12].
In this work, the interaction of a Schiff-Base calix[4]arene with calf thymus DNA has
been studied. The calixarene investigated has a terminal ester group on the lower rim
and an ortho fused polycyclic arene group in the upper rim (see Scheme 1), with nucleic
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from 200 to 800 nm and data were collected every 2 nm. A standard quartz cell of 10 mm
path length was used. The ct-DNA concentration used was 2.00 × 10−5 mol·dm−3 .
2.2.2. Fluorescence Measurements
Fluorescence emission intensity measurements were carried out using a Hitachi-F-2500
spectrofluorimeter interfaced to a PC for the recording and handling of the spectra. A
standard quartz cell of 10 mm path length was used. Fluorescence titrations were performed at a fixed calixarene concentration of 2.00 × 10−6 mol·dm−3 ; and variable ct-DNA
concentrations in the mole ratio range of X = 0 to 0.2. Experiments at X values higher
than 0.2 were not carried out due to calixarene solubility problems. The excitation and
emission wavelengths were 318 nm and 410 nm, which were the maximum wavelengths
corresponding to the calixarene. Both emission and excitation slits were equal to 10 nm.
2.2.3. Circular Dichroism Spectra
Electronic circular dichroism (CD) spectra were recorded using a Biologic Mos-450
spectropolarimeter. A standard quartz cell of 10 mm path length was used. Scans were
taken from 220 to 320 nm for the intrinsic region. Each spectrum was obtained from an
average of 10 runs at a fixed temperature of 298.2 K, with a 5 min equilibration before each
scan. The results obtained were expressed in terms of molar ellipticity.
Spectra were registered at a fixed ct-DNA concentration and varying amounts of
calixarene to obtain the appropriate molar ratio X (X = [calixarene]/[ct-DNA]).
2.2.4. Viscosity Measurements
Viscosity measurements were carried out using an Ostwald microviscometer, calibrated for water and methanol, immersed in a thermostated water bath at a temperature
of 298.2 ± 0.1 K. Each measurement was repeated at least ten times. The viscosity of the
ct-DNA–calixarene solutions was expressed as the relative viscosity ηr , defined as η/ηo ;
that is, the ratio between the viscosity of the working solution and the viscosity of the pure
solvent (methanol/water at pH = 7 with a sodium cacodylate buffer).
2.2.5. Melting Measurements
The thermal denaturalization study was performed on a Biologic spectrophotometer
equipped with a Peltier temperature controller, which permitted the control of the speed
at which temperature changes during the experiments. The rise in temperature was
0.2 ◦ C min−1 . The recording chart read temperature and absorbance differences between
the reference and the sample cuvettes at 260 nm.
All melting measurements were performed at a fixed ct-DNA concentration of
1.20 × 10−5 mol·dm−3 .
2.2.6. AFM Measurements
The images were obtained with a Molecular Imaging PicoPlus2500 AFM (Agilent
Technologies). Silicon cantilevers (Model Point-probe, Nanoworld) with a resonance
frequency of around 240 kHz and nominal force constant of 42 N/m were used. All AFM
imaging were recorded in air and in tapping mode, with scan speeds of about 0.5 Hz, with
data collection at 256 × 256 pixels.
Due to the large size of ct-DNA, dilute solutions (0.3 µmol dm−3 ) were used to image
isolated ct-DNA molecules. AFM images were obtained by drying 30 µL of calixarene
and ct-DNA solution previously deposited on a modified mica surface. This surface was
prepared by dropping a 0.1% (v/v) APTES aqueous solution onto a freshly cleaved mica
surface. The surface was washed with ultra-pure water and air dried after 20 min. The
calixarene/ct-DNA solution dropped onto the modified surface was incubated for 30 min,
washed with pure water, and air dried prior to AFM imaging.
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Figure 1. Stability of a calixarene/ct-DNA solution (X = 0.008 and [ct-DNA] = 2.00 × 10−5 mol·dm−3 ).

Figure 1. Stability of a calixarene/ct-DNA solution (X = 0.008 and [ct-DNA] = 2.00 × 10−5 mol∙dm−3).
Fluorescence emission spectroscopy is a technique frequently used to obtain information about the binding mode of different species to ct-DNA. Normally, the interaction of
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shows the dependence of the calixarene-ct-DNA solutions fluorescence emission intensity
(EI), at 410 nm, on the molar ratio X. The results obtained demonstrate that, at small X
values, there is a decrease in the emission intensity when the DNA concentration increases.
However, from a value around X = 0.005, the emission intensity began to increase until it
reached a more or less constant value. No shift in the emission band of the macrocycle was
observed. Therefore, the fluorescence was due to the excitation of two polycyclic aromatic
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groups (present in the fluorine groups) in the calixarene structure. These groups have
a planar symmetry, so it is possible that they are intercalated between the base pairs of
the polynucleotide. In fact, this intercalation could explain the observed decrease in the
emission intensity at low X values, since a change in the hydrophobic environment of the
fluorene groups could cause a decrease in the EI. As the value of X increases, the emission
intensity also increases. This observation may be due to the formation of calixarene dimers
at the fluorine sites in the structure, when the polynucleotide concentration diminishes.
The formation of calixarene dimers due to π–π type interactions between aromatic rings has
previously been shown in the literature for this compound [16]. The appearance of these
dimers would imply changes in the intensity of the fluorescence emission, not only because
the environment of the emitting molecules can change, but also because it could reverse the
Chemosensors 2022, 10, x FOR PEER REVIEW
7 of 18
equilibrium of the calixarene/ct-DNA complex formation, favoring calixarene-calixarene
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intensity of the bound calixarene; that is, that of the calixarene-ct-DNA complex [21].
Equation (2) does not explain or fit the experimental data in the X range 0–0.005.
BearingEquation
in mind2 the
of the
calixarene
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the formation of
doesstructural
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or fit the experimental
data
in the X range
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the structural
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of the calixarene
the formation
of dimers
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atmind
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must bemacrocycle,
considered.
Therefore,
the equilibrium
at the surface of the polynucleotide must be considered. Therefore, the equilibrium
must be taken into account in Equation (2), resulting in the following equation:
𝑲𝟐

calix/ct-DNA + calix ↔ (calix)2/ct-DNA (3)

K

calix/ct − DNA + calix ↔2 (calix)2 /ct − DNA

must be taken into account in eq. 2, resulting in the following equation:

(3)

𝐾2

(3)

calix/ct-DNA + calix ↔ (calix)2/ct-DNA
I
=
I0
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K
=
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×
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1
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of calixarene dimers with different douand K2 = 219 mol−1 dm3 were obtained. This K1 value agrees with those obtained by
ble-stranded nucleic acids [11].

Zadmard et al. in the study of the association processes of calixarene dimers with different
double-stranded nucleic acids [11].
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Figure 3. Dependence of the I/I0 ratio of the difluorene-calixarene diester/ct-DNA solution on the

Figure 3. Dependence of the I/I0 ratio of the difluorene-calixarene−6diester/ct-DNA
solution on the
polynucleotide concentration ([calixarene]= 2.00 × 10 mol·dm−3 ). The solid line corresponds to
polynucleotide concentration ([calixarene]= 2.00 × 10−6 mol∙dm−3). The solid line corresponds to the
the multiparameter fit obtained using Equation (4). Error bars represent the standard deviation for
multiparameter fit obtained using Equation (4). Error bars represent the standard deviation for
each polynucleotide concentration value (n = 5).
each polynucleotide concentration value (n = 5).

To further investigate the interactions between the Schiff Base calixarene and the
ct-DNA, circular dichroism (CD) measurements were performed at different X values.
Circular dichroism spectra of calixarene-ct-DNA solutions were carried out at a constant polynucleotide concentration and different macrocycle concentrations. These studies
were intended to determine possible conformational changes in the ct-DNA molecules due
to their interactions with the calixarene. ct-DNA in aqueous solution adopts a right-handed
B-form conformation, showing a characteristic CD spectrum in the near ultraviolet region
(220–320 nm). The spectrum showed a positive band at approximately 278 nm and a
negative one at 247 nm. These bands are caused, respectively, by the π–π stacking interactions between the base pairs and by the helical superstructure of the polynucleotide that
generates an asymmetric environment for the bases [22]. The conformational alterations
of ct-DNA, caused by its interaction with different ligands, produces changes in its CD
spectrum [23,24]. Given that a MeOH/H2 O mixture was used as solvent because of the low
solubility of the calixarene, a preliminary study was carried out to check the effect of the
MeOH percentage on the CD spectrum of ct-DNA. The results (see Figure 4) showed that
the characteristic bands of the CD spectrum of ct-DNA do not undergo any modification in
the presence of the content of alcohol used in the present work.
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out to check the effect of the MeOH percentage on the CD spectrum of ct-DNA. The
do not undergo any modification in the presence of the content of alcohol used in theresults (see Figure 4) showed that the characteristic bands of the CD spectrum of ct-DNA
present work.
do not undergo any modification in the presence of the content of alcohol used in the
present work.
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Figure 5 shows the molar ellipticity dependence of the positive and negative bands

Figure 5 shows the molar ellipticity dependence of the positive and negative bands of
Figure 5 shows
the molar ellipticity dependence of the positive and negative bands
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ct-DNA
spectrum
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of the ct-DNA CD spectrum on the X value.

Figure 5. Dependence of the molar ellipticity of the positive (A) and negative (B) bands on the molar
ratio X ([ct-DNA] = 2.00 × 10−5 mol·dm−3 ). Error bars represent the standard deviation for each X
value (n = 10).

As can be seen, the molar ellipticity of both bands decreases within the range
0 < X < 0.002. In addition, although the profile or shape of the spectrum remained constant
throughout the range of X values studied, the bands showed a bathochromic shift of
approximately 3 nm when X increased (see Figure 6). This observed shift could be related
to the polynucleotide denaturation; that is, the separation of the ct-DNA double helix,
resulting in two single-stranded ct-DNA molecules [17]. Since the ct-DNA chains are held
together by hydrogen bonds between complementary base pairs, a possible intercalation of
the macrocycles between them could disrupt the hydrogen bond between the base pairs
thereby affecting the spectrum. Another possibility, mentioned previously, is the potential
formation of calixarene dimers which may also affect the conformation of ct-DNA. To obtain
additional information on this issue, viscosity and melting temperature measurements
were performed.

together by hydrogen bonds between complementary base pairs, a possible intercalation
of the macrocycles between them could disrupt the hydrogen bond between the base
pairs thereby affecting the spectrum. Another possibility, mentioned previously, is the
potential formation of calixarene dimers which may also affect the conformation of
ct-DNA. To obtain additional information on this issue, viscosity and melting9 temperaof 16
ture measurements were performed.
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The initial increase in viscosity could correspond to a denaturation of the doublestranded
due to the
calixarene/ct-DNA
interactions.
To investigate
this possibility,
To gain furtherct-DNA,
information
about
how the calixarene
molecules
interact
with
the viscosity of calixrene/ss-DNA solutions was investigated (Figure 7B). In this case, a
ct-DNA, measurements of the melting temperature, Tm, were performed. This temperconstancy of viscosity was observed in the range of X from 0 to 0.003.

ature was determined as the average of the initial and final temperatures corresponding
to the melting process. The profiles were sigmoidal for all X values studied (Figure 8).
The ct-DNA melting transition was highly cooperative (ΔT ≈ 10–15 °C, see Figure
8A,B,D–F). However, a less cooperative trend was obtained for X = 0.003 for the Schiff
Base calixarene (ΔT ≈ 30 °C, see Figure 8C). A less cooperative transition happens if a
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Subsequently, the relative viscosity of the ct-DNA solution decreased with increasing
concentration of the macrocycle, as occurred with the double stranded ct-DNA. The explanation for this behavior will be provided later. The results suggest that polynucleotide
denaturation occurs at low X values due to the calixarene/DNA interaction.
To gain further information about how the calixarene molecules interact with ct-DNA,
measurements of the melting temperature, Tm, were performed. This temperature was
determined as the average of the initial and final temperatures corresponding to the melting
process. The profiles were sigmoidal for all X values studied (Figure 8). The ct-DNA melting
Chemosensors 2022, 10, x FOR PEER REVIEW
12 of 18
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Figure 9 shows the dependence of Tm on the molar ratio X. An initial decrease in
melting temperature was observed in the range of X from 0 to 0.003. A further increase in X
resulted in an increase in Tm. It is seen that the values of X where a minimum point of Tm
was observed coincided with those observed from the viscosity measurements.
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Figure 9. Melting temperature values
obtained at different X values for the calixarene/ctsolutions ([ct-DNA] = 1.20 × 10−5 mol·dm−3 ). Error bars represent the standard deviation for each
DNA solutions ([ct-DNA]= 1.20 × 10−5 mol ∙ dm−3). Error bars represent the standard deviof Xvalue
(n = 3).
ation value
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When a ligand intercalates between the base pairs of the polynucleotide, without
affecting the separation of the double helix, an increase in the rigidity of the ct-DNA double
helix
and
a prevalence
of the
B formaggregates
happen [27].
This
would
result
in state
an increase
in Tm
Supian
et al.
observed that
calixarene
were
formed
in the
solid
for
be accompanied
changes
polynucleotide.
Schiffand
Basecould
calix[4]arenes,
in which by
the conformational
molecules stack one
inside in
thethe
other
[16,32]. There- Fluorene
(and derivatives)
known
to interact
with ct-DNA
intercalation
between the
fore, groups
supramolecular
aggregatesare
may
have formed
in solution
for thisby
calixarene
ligand.
base pairsofofthese
the polynucleotide
[28,29].
Thus,atthe
calixarene
could
be intercalated into the
The formation
aggregates would
be favored
high
macrocycle
concentrations.
ct-DNA backbone through the fluorene groups. Since an initial decrease in the melting
Thus, the behavior
observed at
in low
our studies
using
techniques
forcalixarene
X values with the
temperature
was observed
X molarhere
ratios,
themany
interaction
of the
> 0.003
may be due towould
the formation
of supramolecular
aggregatesinteraction,
in the solution,
which
polynucleotide
most likely
occur via a groove-type
causing
the breaking
would
by increasing
the concentration
of the
If such
aggregates
of be
thefavored
hydrogen
bonds between
the base pairs
andmacrocycle.
destabilization
of the
double helix due
stabilize
calixarene
molecules
in the
aqueous
solution,
addition
of morehas
calixarene
to athe
partial
separation
of the
double
strand.
Thisthe
type
of behavior
been previously
2+
to theobserved
medium for
would
weaken
the
calixarene/ct-DNA
interactions.
The
released
other species. For example, Cu ions induce a break in thepolynuhydrogen bonds
cleotide
molecules
would
then
revert to
a moreto
extended
conformation,
similar
to helix
the in-[30]. Other
between
guanine
and
cytosine,
leading
a destabilization
of the
double
itial one.
2+
2+
2+
2+
ions such as Zn , Mn , Ni , and Co also cause destabilization of the double ct-DNA
helix at high concentrations [31]. The increase in the melting temperature observed for
To obtain information on the structure of the calixarene/ct-DNA complexes, atomic
X > 0.003 suggests changes in ct-DNA conformation.
force microscopy (AFM) measurements were performed. Figure 10 shows the results obSupian et al. observed that calixarene aggregates were formed in the solid state for
tained. In the absence of calixarene the typical elongated form of the ct-DNA molecules
Schiff Base calix[4]arenes, in which the molecules stack one inside the other [16,32]. Therewas observed. At low X values, the macrocycle interacts with the polynucleotide, inducfore, supramolecular aggregates may have formed in solution for this calixarene ligand.
ing an increase in the bending of the ct-DNA molecules. This increase results in a decrease
The
formation
of these
aggregates
would
be favored
at high macrocycle
concentrations.
in the length
persistence,
which
leads to the
formation
and stabilization
of intramolecular
Thus,
the
behavior
observed
in
our
studies
here
using
many
techniques
for
values >0.003
loops (see Figure 10 A-B). Here, stabilization occurs by the formation of flower- and X
discmay
be
due
to
the
formation
of
supramolecular
aggregates
in
the
solution,
which
would
like structures, which are considered to be a type of strand-with-strand stabilization, as
be
favored
by
increasing
the
concentration
of
the
macrocycle.
If
such
aggregates
stabilize
reported Fang and Hoh [33,34]. For X > 0.003, a structural change of the polynucleotide
calixarene
molecules
in the
solution,structure
the addition
of more
calixarene
to the
fromthe
a more
compact
(partial) state
to aqueous
a more extended
is observed.
Hence,
a
medium would
the calixarene/ct-DNA
interactions.
The compact
releasedstrucpolynucleotide
decompaction
processweaken
was produced,
as evident from Figure
10 C-D. The
then
revert
to a more
similarstructures
to the initial one.
turesmolecules
appear to would
be further
apart,
perhaps
dueextended
to the lossconformation,
of loops. Pearl-ring
To new
obtain
information
structure ofcould
the calixarene/ct-DNA
complexes,
atomic
appear. This
arrangement
of on
thethe
polynucleotide
be due to the stacking
of the
calixarene
in solution,
to form aggregates
(asperformed.
can be seen in
Figure10
2 at
valuesthe results
force molecules
microscopy
(AFM) measurements
were
Figure
shows
of X >obtained.
0.003), which
ultimately
produce
weakening
of the interactions
between molecules
In thewould
absence
of calixarene,
thea typical
elongated
form of the ct-DNA
was observed. At low X values, the macrocycle interacts with the polynucleotide, inducing
an increase in the bending of the ct-DNA molecules. This increase results in a decrease in

Chemosensors 2022, 10, 281

12 of 16

the length persistence, which leads to the formation and stabilization of intramolecular
loops (see Figure 10A,B). Here, stabilization occurs by the formation of flower- and disclike structures, which are considered to be a type of strand-with-strand stabilization, as
reported by Fang and Hoh [33,34]. For X > 0.003, a structural change of the polynucleotide
from a more compact (partial) state to a more extended structure is observed. Hence, a
decompaction process was produced, as evident from Figure 10C,D. The compact structures
appear to be further apart, perhaps due to the loss of loops. Pearl-ring structures appear.
This new arrangement of the polynucleotide could be due to the stacking of the calixarene
molecules in solution, to form aggregates (as can be seen in Figure 2 at values of X > 0.003),
which
Chemosensors 2022, 10, x FOR PEER REVIEWwould ultimately produce a weakening of the interactions between the calixarene
13 of 17
and the ct-DNA. Therefore, a less compact structure would occur which agrees with the
results found from the other techniques.
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calixarene as a vector, it is essential to examine the viability of various cell lines in the
presence of different calixarene concentrations. With this in mind, the cytotoxic effect that
the macrocycle exerts on different cell lines was measured. These studies were performed
over a 48-h time period. The results are shown in Figure 12.
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Cytotoxicity data indicate that the Schiff Base calixarene has the potential to be u
as nanovector up to 0.32 µ mol dm−3 (~75% cell viability in RPE-1 cells), as well
nanocarrier for anticancer drugs such as doxorubicin, cytarabine, paclitaxel, among o
ers, as has been demonstrated with other calixarenes [37].
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